TP53 MUTATIONS IN CODON 273 IS PREDICTIVE OF OVERALL SURVIVAL IN ASTROCYTOMA PATIENTS

被引:0
|
作者
Noor, H. [1 ]
Rapkins, R. [1 ]
McDonald, K. [1 ]
机构
[1] Univ New South Wales, Sydney, NSW, Australia
关键词
D O I
10.1093/neuonc/noz126.111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P04.16
引用
收藏
页码:32 / 32
页数:1
相关论文
共 50 条
  • [1] TP53 mutations and codon 72 genotype -: impact on survival among ovarian cancer patients
    Wang, Y.
    Kristensen, G. B.
    Borresen-Dale, A.-L.
    Helland, A.
    ANNALS OF ONCOLOGY, 2007, 18 (05) : 964 - 966
  • [2] TP53 mutations impair overall survival in ALK plus lung adenocarcinoma
    Christopoulos, P.
    Kirchner, M.
    Bozorgmehr, F.
    Endris, V
    Elsayed, M.
    Penzel, R.
    Herth, F.
    Heussel, C. -P
    Winter, H.
    Muley, T.
    Meister, M.
    Fischer, J. R.
    Rieken, S.
    Lasitschka, F.
    Bischoff, H.
    Schirmacher, P.
    Thomas, M.
    Stenzinger, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 291 - 292
  • [3] The TP53 Codon72 Polymorphism Is Associated with TP53 Mutations in Chronic Lymphocytic Leukemia
    Grossmann, Vera
    Artusi, Valentina
    Schnittger, Susanne
    Dicker, Frank
    Jeromin, Sabine
    Boeck, Lucia
    Haferlach, Torsten
    Haferlach, Claudia
    Kern, Wolfgang
    Kohlmann, Alexander
    BLOOD, 2011, 118 (21) : 778 - 778
  • [4] TP53 mutations and Their Impact on Survival in Patients with Myeloproliferative Neoplasms
    Rolles, Benjamin
    De Oliveira Filho, Cilomar Martins
    Keating, Julia
    Luskin, Marlise R.
    DeAngelo, Daniel J.
    Lindsley, Coleman
    Kim, Annette S.
    Hem, Jessica
    Kim, Chulwoo J.
    Weeks, Lachelle D.
    Wazir, Mohammed
    How, Joan
    Marneth, Anna E.
    Liu, Yiwen
    Aryee, Martin J.
    Tsai, Harrison K.
    Stahl, Maximilian
    Mullally, Ann
    BLOOD, 2023, 142
  • [5] TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas
    Lima-Ramos, Vitor
    Pacheco-Figueiredo, Luis
    Costa, Sandra
    Pardal, Fernando
    Silva, Ana
    Amorim, Julia
    Lopes, Jose Manuel
    Reis, Rui Manuel
    CANCER GENETICS AND CYTOGENETICS, 2008, 180 (01) : 14 - 19
  • [6] Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
    Kyndi, M
    Alsner, J
    Hansen, LL
    Sorensen, FB
    Overgaard, J
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S54 - S54
  • [7] Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
    Loeb, Keith R.
    Asgari, Maryam M.
    Hawes, Stephen E.
    Feng, Qinghua
    Stern, Joshua E.
    Jiang, Mingjun
    Argenyi, Zsolt B.
    de Villiers, Ethel-Michele
    Kiviat, Nancy B.
    PLOS ONE, 2012, 7 (04):
  • [8] TP53 mutations impair overall survival of TKI-treated patients with oncogene-driven NSCLC
    Christopoulos, P.
    Kirchner, M.
    Bozorgmehr, F.
    Endris, V.
    Elsayed, M.
    Magios, N.
    Volckmar, A-L.
    Penzel, R.
    Herth, F. J. F.
    Heussel, C. P.
    Winter, H.
    Muley, T.
    Meister, M.
    Fischer, J. R.
    Rieken, S.
    Lasitschka, F.
    Bischoff, H.
    Schirmacher, P.
    Thomas, M.
    Stenzinger, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer
    Foedermayr, Mathilde
    Sebesta, Miriam
    Rudas, Margaretha
    Berghoff, Anna S.
    Promberger, Regina
    Preusser, Matthias
    Dubsky, Peter
    Gnant, Michael
    Steger, Guenther G.
    Weltermann, Ansgar
    Zielinski, Christoph C.
    Zach, Otto
    Bartsch, Rupert
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2016, 9 (02) : 70 - 75
  • [10] The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas
    Langerod, A
    Bukholm, IRK
    Bregård, A
    Lonning, PE
    Andersen, TI
    Rognum, TO
    Meling, GI
    Lothe, RA
    Borresen-Dale, AL
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (12) : 1684 - 1688